dare initi outperform
initi cl share outperform
rate price target pt reflect re-
rate back histor premium xlp
stapl sector multipl ep cl
stall past month
macroeconom factor latin america asid
controversi center whether colgat busi
model broken level reinvest
would case need fix run
effici oper yield high margin cl
earn highest global hpc
effici also bring degre inflex turn
dime confus
concern colgat might over-
earn consid follow
oral care industri remain healthi
premium shift natur
therapeut segment cl under-
repres strateg pivot ceo
cook outlin septemb redirect
spend segment
relaunch core multi-benefit colgat
total franchis reacceler broaden
colgat gillett averag colgat
product retail discount
competitor gillett way
consum oral care trade
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest decis
litmu test over-earn concern ought cl-latin america firm profit
risk earn rebas addit prospect offset cost higher
price detail analysi cl product program suggest avail
increment save reinvest right innov moreov expect
construct competit emerg enterpris market account
colgat sale mind fx risk cl strike us better posit
ramp invest appreci
structur part cl person care busi becom less attract ceo
transit colgat moreov rais probabl larger deal one ideal
would recalibr product portfolio probabl toward skincar consist two recent
bolt-on creat save and/or geograph diversifi compani growth sourc
ad scale exposur asia pacif
brazil macro stay lousi much longer time initi oral care dont gain
traction prove expens probabl deal would increas colgat financi
disciplin legendari opportunist
cl dare love
initi outperform pt
tabl content
invest summari recommend
compani overview strategi
colgat over-earn
growth algorithm outlook
categori overview cl posit
play catch-up therapeut natur
local player challeng cl lead china
drive premium brazil
lose share local player india
competit rivalri strongest
person recalibr soap skincar
prioriti four
initi w/outperform
despit investor concern firm core oral busi remain one best stapl
franchis case out-performance reflect convict colgat capac recalibr
portfolio busi model restart market share gain widen leadership
challeng structur expens deal street fear like
manag restructur save back-end load cl afford higher reinvest
power
pt reflect re-rat back histor premium xlp stapl sector multipl
ep growth
oral care categori fundament remain solid consum trade region new
competitor higher price point often natur product claim greater efficaci
support categori premium develop emerg market
cl perhap late game understand trend alreadi regain share india like
use plug high end hole introduc swiss elmex market relaunch
global effect premium colgat total
pg organiz chang announc benefit competit dynam
colgat emerg market sale
contrarian call dare love
dare investor love cl even mani year under-perform sell-sid
recommend stock
cl under-perform last year
cl under-perform xlp last year
report rate buy sell hold
oper colgat left weak note releas januari
turnaround initi kick
busi model broken
contrari bear believ cl model broken see need
expect improv latin american result perfect storm weak economi higher
cog fx pressur hurt cl unilev start follow cl price
expect margin recoveri despit continu end market challeng
cl over-pr product cl oral person care product tend retail
price competit cl gillett
cl under-invest advertis remain healthi sale cl
invest signific amount in-stor execut get deduct sale
save program backend load see restructur save
support colgat total relaunch growth initi page
need work e-commerce cl play catch-up partli oral care
migrat on-line slower pace vs categori like make-up diaper
portfolio may need work
colgat portfolio strategi financi disciplin creat attract sharehold valu
time ceo ian cook colgat grown sale msd rate oper margin bp
annual sinc last month proven cl toughest sinc period led
restructur merger talk gillett
like colgat new ceo may see portfolio adjust
cl lost ground unilev -- formid focus competitor person care
also run much lower oper margin
respons cl seem de-emphasize certain categori -- bath soap deodor
unilev core
also seen bolt-on acquisit dermatolog direct-to-consum skincar view
move learn opportun possibl pave way someth substanti
acquisit ad scale exposur asia pacif make sens given firm relianc
latin america press report indic cl may bid china oral care compani weimeizi
hill pet nutrit busi look solid homecar remain scale play
pg new strategi org structur posit cl
 gs new strategi organiz structur net invest posit remain
underappreci juli pg start oper new structur bulk
firm busi emerg market assum profit respons first time year
chang mark departur fund expans emerg market profit earn
develop market common stapl strategi
exampl pg sought deliv revenu synergi gillett merger came
oral toothbrush start pg sought global product increas
cl cost busi key market brazil
go forward expect balanc growth profit strategi pg defin
enterpris market -- emerg market india brazil
 domin earn oper margin
colgat lead oral care pg advantag una
expect balanc growth profit strategi
 gs enterpris cl sale
construct structur toothpast signific share
advantag cl gs enterpris market
colgat gsk
focu market includ north america western europ russia china
enterpris market rest world
euromonitor segment base gs definit evercor isi analysi
colgat unilev
improv lat upsid per extra point
growth assum vs
decad develop new total formula subject grant patent
pend patent applic relaunch schedul around super bowl seek
restart trade-up within colgat toothpast portfolio
basic anti-cav colgat red account
cl toothpast volum total
total retail approx premium red
conserv total would retail
price cl gener pt price one five
user red trade total exclud
toothpast retail premium total
challeng structur expens fear
like manag restructur save back-end load
oral care increas brush frequenc flat
balanc busi
trade-up oral care price power emerg
market off-set europ deflationari pressur
colgat over-earn street fear reinvest like
manag restructur save back-end load cl afford
higher reinvest power
consensu extrapol share loss bric countri
flat growth
consensu fear cl over-earn broken busi
expect re-rat investor confid return
cl trade one-standard deviat share histor premium
stapl sector -- lowest rel valuat sinc
earli possibl
expect weak new product shelv februari clear old inventori old
product like depress shipment retail special
colgat earn hpc highest margin support view over-earn effici op
creat inflex turn dime shouldnt confus broken busi
consid follow
 oral care remain healthi premium shift natur therapeut segment
cl under-repres septemb strateg pivot redirect spend segment
cl gillett colgat product retail discount peer gillett way
 volum latin america cl profit growth center grow stapl
contract declin seem temporari brazil truck strike cl price lead
posit cl pg like posit ko
oral care repres cl pg sale respect pg reorg could lead
construct competit enterpris market account cl-global sale
pt estim look amongst highest street
analys indic cl challeng expens street fear manag
restructur save back-end load cl afford higher reinvest
fear rebas overearn weak end
earn purgatori fx risk ep
relentless macro latin america cl key
profit center limit visibl earn
cyclic factor could delay recoveri
confid cl price power
miss gross margin expans compound
fear cl busi model broken
reactiv proactiv approach digit
product innov
ep pois rebound price
relaunch colgat total
price competit seem let
unilev lead price brazil
ceo transit rais probabl assert
recalibr portfolio
management credibl cl stock investor want
vs skeptic sell-sid
pivot therapeut oral care could restart
premium lift return media
valuat support base fair valu
estim per cl share
challeng turnaround kick
construct stanc reflect convict strateg pivot ceo cook outlin
key initi relaunch colgat total earli
ep match consensu reflect contract oper profit owe fx
commod weak sale europ
 retail sale weaken vs pressur point toothpast dishwash
there earli evid improv dishwash non-cor categori innov
schedul februari relaunch colgat total toothpast colgat hydri therapeut oral
rins dri mouth relief
brazil account colgat sale like higher percentag profit neg
improv impact trucker strike ii consum sentiment
structur colgat benefit develop modern drugstor chain carri
premium oral care line colgat profession elmex
fx commod
estim anoth point fx impact headwind swing factor
price particularli brazil india unilev lead
base spot price commod pressur taper therefor posit
 sale forecast flat
oral care weaken ahead global relaunch
colgat total
relaunch total aim restart trade-up
tom main
basic anti-cav toothpast account
colgat sale
categori
ajax lost distribut privat label retail shelv ajax yield higher
return carri privat label henc start see ajax recoveri
acv weight point distribut
/point distribut
evercor isi vs street
lead share oral care structur attract categori
straddl person health care account
half compani portfolio
advantag busi built trust parti influenc
dentist vet dermatologist consum
knowledg decentr manag deep bench
exposur emerg market
multi-year product program fund growth plu
financi disciplin render highest stapl
follow gs chang strategi organ
competit intens amelior
acquisit emerg oral dermatolog skincar
e-commerce exposur asia pacif
premium oral care portfolio launch
swiss gaba line gain traction china brazil
global restag colgat total
drive effici trade spend slot fee leverag
overexposur latin america instil volatil hurt
financi perform underexpos high growth
emerg market asia pacif
care busi becom financi unattract
disadvantag unilev
oper highest level effici leav modest
room maneuv
behind e-commerce digit invest vs peer
global competitor oral care unilev gsk
deep pocket commit grow share
natur therapeut oral care drive growth
colgat multi-benefit brand yet gain traction
local brand gain scale natur oral care bric
countri targets/ bolt-on scarce/ unreli
unilev beiersdorf reinvest heavili focus
grow person care colgat sub-scal
retail shift china macro brazil could delay
pass-through input cost commod
compani overview strategi
colgat sec file euromonitor evercor isi research analys estim
cl portfolio brand geographi divis
cl largest household person
cl portfolio complex appreci
care
ceo ian cook appoint oral care increas sale
sale categori
colgat strateg financi disciplin
structur attract categori colgat compet firm competit
advantag geograph footprint
estim gross margin oral vs high forti home term growth
oral person care offer better prospect consum spend increas incom
support premium spend home care tend flatten
product save home therefor like fund oral care initi
pet care also experi trade-up specialti therapeut pet food
colgat advantag strong share reflect
knowledge-bas busi model relationship trust expert
influenc dentist vet recent dermatologist
emerg market footprint colgat sale emerg market earn
profit margin compar enjoy higher growth
care sale unlik care shrunk
relev part due asset dispos colgat lost share person care share loss reflect
strateg de-emphasi cl dictat firm financi disciplin competit unilev
made categori less attract
region global palmol menem irish spring soft soap brand
skew financi less attract categori within person care soap bath
sub-scal unilev earn will earn much lower margin well
colgat
unlik cl unilev manag care busi growth emerg market like
brazil una like keep rais reinvest bar categori like deodor bath
cl neither brand financi incent dig
what cl dip toe dermatolog skincar nich that financi attract
oral care bolt-on dermatolog skincar
gross margin busi estim
colgat over-earn
think model broken think brand innov qualiti
engag materi meaning drive busi go forward
impli compani activ think so-cal rebas
colgat over-earn
perfect storm past month
headwind moder go forward
chang categori retail manag
colgat over-earn
bear suggest risk price reset like gillett and/or earn rebas like coti
research suggest macro headwind manag commerci challeng
fact last month seen slowest top line growth year flat price
time sinc broad-bas market share loss bp gross margin
fact top line growth gross margin larg constrain perfect storm macro
headwind mani could moder next month
believ chang categori retail look manag initi outlin
septemb restart share gain portfolio premium
evid need broad price reset like gillett
cl starv busi
 gs new strategi organiz structur posit cl key emerg
cl slowest top-line growth year
organ sale growth averag
long-term target temper reflect uncertainti macro
cl sale under-perform peer bp
year
colgat vs unilev person care
recent septemb
sourc compani sec file evercor isi estim analys
cl lost share ytd
cl top-line vs industri growth weight colgat categori exposur
trade-up natur therapeut
colgat over-earn
perfect storm past month
headwind moder go forward
chang categori retail manag
perfect storm past month
confluenc headwind past month result perfect storm
pressur cl top line growth gross margin
overexposur latin america suffer tough macro
fx devalu latin america reduc organ sale growth
commod inflat transact fx pressur
price usual time gap input/ fx-transact cost hit profit
restor price increas time differ
cl under-repres natur therapeut oral care
henc low return increas ad spend
cl overexpos latin america vs peer
latin america global sale
macro remain weak vs asia pacif
latin america challeng everyon
cl lat volum grow
fx turn organ growth report declin
rest world
sale latin america
rest world
sale latin america
emerg market growth hurt fx
gross margin bp past month
impact gm
impact gm
sourc colgat sec file earn call evercor isi estim
colgat over-earn
perfect storm past month
headwind moder go forward
chang categori retail manag
headwind moder
packag raw materi inflat seem stabil spot basi
flow cog next month
price alway lag commod inflat higher transact cost expect higher
retail price off-set cost drive cl top-line latin america
see structur chang competit retail consum behavior
impair key categori said cl-person brand latin america could
remain pressur unilev beiersdorf
import unilev announc price increas latin america
base case eventu macro recoveri brazil could drive upsid consensu
consum busi confid brazil improv sinc elect
commod price y/i flow
cog next month
commod transact impact gm bp vs spot
increment inflat
year chang spot price cl basket commod
price off-set commod fx lag
unilev announc price increas
cl-price recov fx impact
cl-price pass commod inflat
cl price bar chang commod price lie
improv sinc elect
brazil new presid promis signific break prior administr polici
rampant corrupt
colgat over-earn
perfect storm past month
headwind moder go forward
chang oral care categori retail manag
chang categori retail manag
chang categori retail look manag initi outlin septemb
restart share gain premium point
oral care initi posit colgat better captur segment shift
evid need broad price reset
cl starv busi reinvest
pg new strategi organiz structur posit cl
cl appear lag e-commerce view need catch-up
oral care initi better posit cl
believ colgat oral care initi announc septemb better
posit firm captur consum trade therapeut natur segment
enter therapeut china brazil premium price elmex emphas swiss
introduc colgat natur india russia china
oral section begin page analysi
colgat gillett overearn
tom main
price
colgat gillett overearn ii
price
colgat gillett overearn
price
colgat gillett overearn iv
price
cl starv busi reinvest
ad spend up sale
ad spend revenu
ad revenu
reinvest ad cl vs peer
revenu
counter current shift therapeut natur dilut
return increas advertis
cl sale slow time increas advertis spend
cl play catch-up partli oral care migrat on-line slower pace
vs categori like make-up diaper
compet digitally-n startup like quip foreo focu
aesthet design electr toothbrush cl took minor stake hubbl
cl show earli traction e-commerce chinase slide
e-commerce sale note cl exclud hill
growth algorithm outlook
ldd tsr algorithm next year
case out-performance reflect convict health global oral care market
colgat capac recalibr portfolio busi model restart market share gain
widen leadership
believ colgat well posit reacceler organ sale growth currenc
neutral ep growth tsr
categori growth return msd-to-hsd emerg market lsd develop one cl
posit mix oral care growth fund growth save sustain bp
fund growth yield mil save cost avoid per year bp
gross margin annual thing equal
back-end load save global growth effici program drive organ oper
incom growth reinvest jump start top-lin growth
program launch extend cl incur anticip billion
one-tim charg increment save weight
gross margin bps/year core oper margin
bps/year averag past year
impact gm
impact gm
sourc colgat sec file earn call evercor isi estim
cl grew op margin bps/ year past year
given fx effici driven earn
gm expand per year
sg ex advertis cut mm
fx headwind report sale ep growth
commod price y/i
flow cog next month
commod transact impact gm bp vs spot
increment inflat
year chang spot price cl basket commod
see appropri natur side would go order
complement portfolio obvious tom main busi one
well-establish natur brand look right
opportun around world expand busi new channel
natur play
strateg see thing natur space mention earlier quit
interest us recogn made perhap mistak
hill busi stretch brand feel
stretch brand natur space given uniqu particular
market look way fill gap
categori overview cl posit
play catch-up therapeut natur
local player challeng cl lead china
drive premium brazil
lose share local player india
competit rivalri strongest
question priorit busi emot connect
consum trust consum product
put mouth kid mouth oral care pet mouth
pet food build brand loyalti give price power give
margin power usual growth
come person care quit emot bond close
interest go journey profession space
solv specif skin care issu recommend
home care ye grab-and-go busi scale
oral care largest categori person care
increment bn retail sale global
sale razor
hair color
hair style fell
increment currency-neutr sale use fx rate base non-dollar denomin sale
oral care penetr privat label
privat label market share america europ across largest hpc categori
oral care segment colgat compet grew
fx neutral basi
contrib
oral care includ dentur care floss mouth freshen recharg electr toothbrush includ
oral care slow bp
per capita spend oral correl incom
spend isnt tie incom also oral
adjust incom brazilian spend oral care american
spend oral care share wallet adjust person incom
consumpt toothpast
spend oral care
share wallet
result usag oral care product vari vastli
innov drive price power trade-up
nation bureau statist china
ministri statist programm implement
bureau labor statist
effect
hair dental shave miscellan person product
bric countri drove categori growth
 market
cl significantli focus competitor
oral care
global sale oral care
cl clearli lead global oral care
gain share time
chang share
cl player strength across region
leadership toothpast toothbrush
bric countri cl portfolio skew oral care
categori overview cl posit
play catch therapeut natur
local player challeng cl lead china
drive premium brazil
lose share local player india
competit rivalri strongest
play catch-up therapeut natur
oral care remain structur attract driver premium shift
past sever year
trade-up continu except slowdown latin america reflect brazil
challeng macro loss venezuela market
consum develop emerg market increasingli seek therapeut
sensit gum health toothpast colgat brand limit traction
macro trend healthier product driven growth natur toothpast colgat
tom main
led local player natur segment driven categori growth india china
left cl play catch
shift left colgat play catch under-index natur
therapeut segment like initi outlin septemb
enter therapeut brazil china gaba/elmex line
reinforc colgat premier multi-benefit toothpast relaunch total
launch colgat natur extens china india russia
may press market bolt-on
within oral care cl underrepres natur
natur therapeut segment grow faster multi-
benefit whiten toothpast
therapeut natur segment grow
faster multi-benefit toothpast global
multi-benefit global categori drive
global growth toothpast
contribut toothpast growth
natur toothpast infus local herb grow
cl tom main
cl miss oral care premium
market share oral share chang vs
cl gain global share multi lag other
tom main
global therapeut segment gsk outpac cl year
cl kept gaba region gsk global
share market present
cl-gaba limit central eastern europ
result cl captur one-third real dollar
growth oral care sinc
adjust cp venezuela approxim cl consolid net sale decemb
oral care initi outlin septemb
enter therapeut china brazil elmex
colgat flanker natur india russia china
cl therapeut line gaba launch china
attempt align extend colgat brand natur
china india russia
cl plan relaunch colgat total could drive trade-up real price/mix
colgat total upgrad relev
total franchis repres colgat toothpast sale
 global respect
success total like sourc share compet multi-benefit brand
 gs crest unilev signal hand market
colgat sell price varieti averag lower toothpast
categori henc afford isnt issu
total work best lesser engag consum contain triclosan
antibacteri fda-approv toothpast ban person care
cl face difficulti premium colgat therapeut benefit pro-
argin sensit fda approv enamel reminer
amazon base lowest promot price
categori overview cl posit
play catch therapeut natur
local player challeng cl lead china
drive premium brazil
lose share local player india
competit rivalri strongest
local player challeng cl lead china
colgat gener global sale china oral care china drive
nearli oral care categori growth global increas frequenc brush
premium main driver
local player yunnan baiyao group weimeizi hold market share much
twelv point past year
yunnan baiyao group make toothpast infus chines govern
protect secret blend herb ynnn biyo
weimeizi saki target young consum pop cultur fashion oral
care recal younger profession often earn older one
retail premium multi-benefit global brand colgat gs crest
cl retain narrow lead darli toothpast colgat darli market
partnership hk-base hawley hazel
follow elmex introduct therapeut cl could refin strategi wherebi
darli align closer naturals/ tradit medicin colgat compet
multi-benefit consumer-driven segment toothpast
market share chang share vs
price per gram index colgat
cl lead darlienot colgat
e-commerce displac tradit channel
china oral care channel distribut
e-commerce earli traction china
toothpast share china tmall
cl price categori
yunnan baiyao llc launch toothpast infus ynnn biyo white
medicin yunnan blend herb rich notoginseng use tradit
chines medicin wound heal
said improv gum health ynnn biyo protect formula
protect well prc ministri scienc technolog secreci
separ ingredi manufactur thirteen differ team none know ingredi team mix
toothpast
toothpast revenu includ
health product divis
baiyao toothpast retail much colgat
sinc certain consum post chines
social media express complaint ingredi
poster claim medic profession express
shock medicin requir prescript purchas
easili includ toothpast broadli
market natur herbal remedi
poster reveal check sever
natur toothpast found ingredi
product well
express disappoint compani claim
herbal cure misrepres realiti
manufactur product ingredi
highli regul
rough translat complaint
yesterday went supermarket buy someth
wasnt much toothpast left home went ahead
took yn baiyao shelf even though toothpast
expens feel brush pretti good ive
alway heard slogan gum bleed use yn
habit doctor scan ingredi box
put box cart saw someth
familiar tranexam acid thought read wrong
toothpast stapl would tranexam acid
hematologist use stop bleed
patient want use medicin theyd need doctor open
prescript come flagrantli put
toothpast god think feel cold sweat
back quickli look herbal toothpast
ingredi felt cold lot anti-bleed
toothpast tranexam acid yn baiyao three seven
say supposedli
claim anti-bleed effect fals advertis what
actual work tranexam acid
compani take event past day serious verifi fact state
social media present provid follow explan aforement
ingredi use yunnan baiyao group follow countri
toothpast ingredi regul relat regul ad illeg
substanc form
tranexam acid wide use within toothpast present within mani
toothpast sold within countri
yunnan baiyao toothpast close examin scienc
profession product long term select effect product
gone complet medic toxicolog clinic studi ensur safeti
effect product
examin product effect mean improv overal oral
recent compani notic intens unusu scrutini certain individu
on-line twist truth even malici manipul event harm compani
hope sourc rumor reveal truth review product legal
year
saki toothpast target younger consum use celebr endors
social media entertain price point par premium colgat crest
what colgate-china
innov key trend launch natur rang digitally-savvi launch on-line
elmex therapeut toothpast import swiss subsidiari gaba
colgat dare love
categori overview cl posit
play catch therapeut natur
local player challeng cl lead china
drive premium brazil
lose share local player india
competit rivalri strongest
drive premium brazil
colgat gener global sale brazil oral care colgat share
leadership mean oral care categori isnt grow cl cant grow given brazil
high level consumpt oral care product pursu premium seem
oral care slow significantli given challeng macro
channel shift pharmaci away hypermarket drive premium
support cl launch swiss line gaba colgat profession
price realiz reliant macroeconom factor consum absorb less
competit
share gain gsk sensodyn provid price umbrella colgat recov
transact cost devalu brazilian vs usd
unilev gs competit posit rel weak delay
derail price increas note alreadi announc price increas
colgat also compet low-end local brand sorriso
market share chang share vs
cl lead defens drug chain gain share
brazil oral care channel distribut
cl side drugstor elmex launch
cl side drugstor oral care like gain share
drugstor
sensodyn price umbrella premium cl portfolio
focu jump-start premium elmex brand cl swiss line gaba
drug chain one key issu brazil import duti impact pricing/ profit
categori overview cl posit
play catch therapeut natur
local player challeng cl lead china
drive premium brazil
lose share local player india
competit rivalri strongest
start regain share
colgat gener global sale india portfolio entir focus oral care
lead market share
colgat recov impact late demonet given rural
india account colgat revenu
cl grow sale mid-singl digit vs unilev growth rate mid teen
reach deeper rural india
colgat lose share due exponenti growth ayurveda-inspir natur oral
care benefit local competitor
bn patanjali ayurv privat cpg conglomer co-found yoga guru
baba ramdev climb posit five year
bn dabur market capit hold posit grow
toothpast
unilev hike price off-set raw materi cost bloomberg
market share chang share vs
india-toothpast market share cl lose share
distribut india remain fragment
constitut barrier entri
compet ayurveda yoga guru
india tradit healthcar ayuverda emphas prevent use compound
natur found plant herb
ayuverda toothpast fad possibl one that root global mega-trend
simpl natur ingredi given belief among larg segment consum
herbal ingredi provid multipl benefit say disinfect anti-
inflammatori properti might well sustain oral care nich may
met colgat tom main brand
toothpast gain share pt sell
patanjali claim ownership ayuverd formula
what colgat vedshakti variant
launch compet local brand repeat strong level
market share move on-going basi inde modern trade
share alreadi beyond know product effect
categori overview cl posit
play catch therapeut natur
local player challeng cl lead china
drive premium brazil
lose share local player india
competit rivalri strongest
competit rivalri strongest
colgat gener global sale oral care competit
rivalri highest decad follow oral acquisit part
gillett gs oral care busi remain domest crest colgat switch
leadership toothpast market share mid
cl narrow long-stand technolog gap tooth whiten vs pg optic
white flanker attempt extend colgat therapeut toothpasteto treat
sensit enamel restor anti plaqu acid dri mouth mix
gsk sensodyn consist gain share
cl establish natur tom main vegan cruelty-fre fluoride-fre
gluten-fre non-gmo competitor mani on-line keep pop pg launch
burt bee toothpast licens
larger issu remain speed oral care migrat on-line compet
model next harri
market share chang share vs
 toothpast colgat gain volum share
cl dollar share remain stabl par pg
gsk sensodyn
growth toothpast come price/ mix
cl vs pg battl leadership leav
money tabl gsk pocket
gsk lead premium toothpast
relaunch total aim restart trade-up
colgat sale
tom main
total largest equiti within colgat toothpast
origin total retail discount toothpast
seek restart trade-up within cl toothpast portfolio switch user anti-cav
red colgat total
multi-benefit segment stagnant cl pg gsk focus narrow
therapeut claim drive premium
asid whiten toothpast segment cl pg lead gsk
succeed segment toothpast therapeut claim sensodyn sensit
bioten dri mouth relief
decad develop new total formula subject grant patent pend
patent applic new version expand total previou claim add new benefit
contain triclosan prior antibacteri anti-gingivati ingredi
new fluorid formula stabil zinc phosphat fight plaque-caus bacteria
mouth surfac includ teeth tongu cheek gum
fight bacteria protect bacteri repopul significantli reduc overal
bacteri load creat protect barrier help shield attach
formula offer addit benefit sensit relief enhanc enamel strength odor
 oral care launch
colgat total relaunch
fast categori migrat on-line
quip launch alreadi hold share on-line behind sonicar
crest colgat oral-b similar listerin tom main sensodyn take
page harri quip launch ahead holiday year
compet quip foreo focu aesthet design electr
toothbrush cl took minor stake hubbl start-up first focus
on-line subscript partner appl
on-line buyer growth quip faster glossier
specialti pet-food larg structur attract categori align trend
toward human pet hill oper subsidiari headquart topeka ks
distribut main line separ specialti channel vet prescript diet
specialti store scienc diet ideal balanc like petsmart petco
 market grow steadili pet-own trade natur
variant giss buffalo cl hill largest specialti brand
pursu differ strategi midst expand distribut
mass retail giss strategi mirror pg -- iam own mar
came expens profit
hill brand equiti built maintain work market vet
pet owner choos brand base vet advic partnership make
hill busi model defens vs buffalo nearli american
shop pet food on-line
nearli hill global sale on-line subscript purchas
alreadi account hill busi
pet nutrit attract categori that premium
human pet improv macro
advantag busi built trust parti influenc
vet pet owner tend brand loyal
focu price support veterinari prescript diet
pet specialti channel scienc diet ideal balanc
cater involv pet owner
knowledg scale continu stream
nestl domin mass market pet food global within
portfolio strategi busi drive corpor top-line
growth leverag busi fund
given differ channel suppli chain technolog
hill doesnt fulli benefit colgat scale
afford specialti pet food emerg market
weakness/ absenc specialti pet store chain latin
hill sale nearli
sale conduct subscript basi
strong economi could acceler format
new household lead increas pet ownership
leverag china tmall develop pet care categori
cl effort drive price mix vs larger pet food
player saddl product/ channel complex
mega trend toward natur creat percept among
pet owner science-bas pet food equat
digit power brand prolifer nois
slow foot traffic specialti store petsmart petco
hill retail launch buffalo largest natur
pet food brand mass retail like
price competit mass channel follow entri
buffalo nestl mar histor retali
aggress impact spill specialti channel
largest amount growth global pet care forecast come latin america
human drive premium
 pet owner agre strongli agre follow statement
consid dogs/ cat part famili
will pay pet food product
healthier pet
enjoy buy pet product pamper dogs/ cat
pet posit impact physic health
pet posit impact mental health
 consum less will trade pet food
unwil trade
will trade
unwil trade dog/cat owner disagre spend less pet product economi
will trade dog/cat owner agre spend less pet product economi
 pet food categori mostli brand low privat label penetr subscription-
type purchas pattern reflect brand loyalti low rate switch
vet influenc choos brand
best inform sourc choos pet food nutrit product
past experi pet food
word-of-mouth pet owner know
staff recommend local/ind pet store
staff recommend pet store chain
endors celebr trust
retail shop channel pet product dog/cat owner
on-line search hill steadili
year year growth
traction flatten
distribut push
hill buffalo oper margin
person recalibr soap skincar
similarli person undertak complet strateg review categori
want natur portfolio speak
aggress way move forward quit excit opportun
cl busi model requir continu recalibr reinvest person vs
home care given lower gm estim low risk neg mix
unlik cl unilev beiersdorf manag care busi growth
emerg market like brazil unilev beiersdorf like keep rais
reinvest bar categori like deodor bath product cl
neither brand palmol protex financi incent dig
view two small acquisit skincar learn deal cl acquir
small sale forc servic dermatologist direct-to-consum busi
take eltamd exampl extraordinarili savvi direct-to-consum
internet strategi asia tremend learn ground us
pca likewis great direct-to-consum e-commerc busi great
busi derm wallac presid
cl- bn sale global sale
cl break-out line busi
colgat distant person care industri
consum trade person care
per capita spend colgat person care categori
person care bath deodor shampoo
colgat categori bath shower deodor basic shampoo grown
sinc vs histor rate brazil contract explain global
contribut delta
rest world
cl manag person profit una growth
cl largest busi latin america yet distant unilev
colgat unilev
recalibr soap skincar
colgat made bolt-on sanex pca skin eltamd
view latter learn deal cl acquir small sale forc servic
dermatologist direct-to-consum busi
prioriti four
street concern cl-home overblown
cl busi model requir continu recalibr reinvest person vs
home care given lower gm estim low risk neg mix
account cl sale reflect statu
firm lowest reinvest prioriti divestitur small brand pg
mid-siz categori lesser prioriti pg una cl exit deterg
brand includ ajax palmol fabuloso clean dishwash
focu emerg market drive categori growth
region strength latin america cl market share pg una
concern competit pressur dishwash cl sale strike us
overblown expect price reset back equilibrium given commod
pg manag home care profit laundri deterg dawn rightli
strateg prioriti dishwash doesnt move needl therefor
chanc price war home care seem low
cl-home bn sale global sale
cl break-out line busi
cl compet mid-siz categori dishwash fabric
compound-annual-growth-rate contrib growth
emerg market drive growth
contrib
consum dont trade home care product
cl global home care categori compet
top compani sale split geographi
pg sale
una sale
cl sale
cl lead america america europ
cl compet palmol vs pg gain
privat label price stabil ajax
valuat price
price target arriv target per cl share base rel intrins valuat
methodolog discount cash flow model point fair valu per
share use wacc growth termin valu base project
ep growth target impli forward price-to-earnings
premium today xlp stapl sector multipl
pt impli regress mean share trade rang re-rat cl
share histor averag predic convict health global oral care
market colgat capac recalibr portfolio busi model restart
market share gain widen leadership believ challeng pressur cl
valuat structur expens deal street fear like
manag restructur save back-end load cl afford higher reinvest
power
risk there limit downsid risk given cl trade one standard deviat
trade averag vs stapl sector model assum improv macro
environ brazil key profit center firm colgat success diversifi
portfolio natur therapeut oral care howev greatest risk stem increas
competit busi outsid oral care home care person care categori
colgat lack financi incent reinvest structur part cl person care busi
becom less attract colgat person care busi compos region brand
miss structur premium categori
valu equiti
valu equiti
sale
oral
incom tax
provis incom tax
less net incom non-controlling
net incom colgate-palmol
net incom oper
provis restructur
chang work capit
non-curr asset liabil
net oper activ
net invest activ
repay long-term debt
addit long-term debt
proce outsid investor
dividend paid sharehold
purchas common stock
proce exercis stock option
net financ activ
increas decreas
equival begin
equival end period
treasuri stock cost
account payabl accru
current portion long-term debt
note loan payabl
promot presid juli
join colgat hold variou global posit market gener manag
appoint vice-president gener manag global toothbrush divis led
colgat busi mexico
becam presid colgat north america also hold respons colgat
becam presid colgat latin america
recent global innov growth hill pet nutrit sinc
acquir gaba hold ag europ
sold under-perform brand fab dynamo arctic power power fresh start
also sold ajax brand laundri deterg us canada
acquir tom main mm founder tom chappel
swap laundri deterg busi colombia sanex person care western europ
unilev
purchas privately-own pca skin eltamd
return sharehold
share buy-back net sale stock mm
like global conglomer household cl oper region
optim product portfolio local especi oral care
sourc colgat evercor isi research analysi estim
colgat unilev
colgat
colgat unilev
colgat unilev
colgat unilev
hill sale op profit
specialti mass
exposur emerg market cl rank
compani data reckitt benckis adjust mead johnson evercor isi estim
scale emerg market cl rank
sort highest lowest exposur em
em sale
compani data reckitt benckis adjust mead johnson evercor isi estim
focu overcom scale emerg market
articl articl
time dissemin januari
analyst yutong zhou javier escalant robert ottenstein primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani
issuer part research analyst compens directli relat specif recommend view
research report
